Virtus ETF Advisers’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,713
| Closed | -$68.8K | – | 682 |
|
|
2024
Q4 | $68.8K | Buy |
22,713
+13,030
| +135% | +$39.5K | 0.03% | 387 |
|
|
2024
Q3 | $35.6K | Buy |
9,683
+174
| +2% | +$640 | 0.02% | 447 |
|
|
2024
Q2 | $38.9K | Buy |
9,509
+3,719
| +64% | +$15.2K | 0.02% | 446 |
|
|
2024
Q1 | $91.3K | Sell |
5,790
-399
| -6% | -$6.29K | 0.05% | 378 |
|
|
2023
Q4 | $93.8K | Buy |
6,189
+2,177
| +54% | +$33K | 0.06% | 390 |
|
|
2023
Q3 | $80.5K | Sell |
4,012
-403
| -9% | -$8.08K | 0.05% | 359 |
|
|
2023
Q2 | $125K | Sell |
4,415
-650
| -13% | -$18.3K | 0.07% | 326 |
|
|
2023
Q1 | $87.1K | Sell |
5,065
-1,945
| -28% | -$33.5K | 0.05% | 368 |
|
|
2022
Q4 | $141K | Buy |
7,010
+2,191
| +45% | +$44.1K | 0.07% | 362 |
|
|
2022
Q3 | $104K | Buy |
4,819
+33
| +0.7% | +$712 | 0.04% | 419 |
|
|
2022
Q2 | $134K | Buy |
4,786
+2,617
| +121% | +$73.3K | 0.05% | 341 |
|
|
2022
Q1 | $100K | Sell |
2,169
-136
| -6% | -$6.27K | 0.04% | 303 |
|
|
2021
Q4 | $194K | Sell |
2,305
-1,489
| -39% | -$125K | 0.07% | 220 |
|
|
2021
Q3 | $253K | Sell |
3,794
-198
| -5% | -$13.2K | 0.11% | 217 |
|
|
2021
Q2 | $212K | Sell |
3,992
-1,827
| -31% | -$97K | 0.09% | 305 |
|
|
2021
Q1 | $252K | Buy |
5,819
+108
| +2% | +$4.68K | 0.11% | 287 |
|
|
2020
Q4 | $297K | Buy |
+5,711
| New | +$297K | 0.12% | 216 |
|